跳至主要内容
临床试验/EUCTR2013-001295-38-AT
EUCTR2013-001295-38-AT进行中(未招募)不适用

An open, single-centre, non-controlled study of efficacy, safety and usability of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at general wards

Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel0 个研究点开始时间: 2013年3月28日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • •- Informed consent obtained after being advised of the nature of the study
  • •- Male or female aged =18 years
  • •- Type 2 diabetes (treated with diet, oral agents, non-insulin injected anti-diabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycaemia which requires s.c. insulin therapy
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1.2 Adults (18-64 years) yes
  • •F.1.2.1 Number of subjects for this age range 50
  • •F.1.3 Elderly (>=65 years) yes
  • •F.1.3.1 Number of subjects for this age range 50

排除标准

  • •- Type 1 diabetes, gestational diabetes
  • •- Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient
  • •- Pregnancy
  • •- Any mental condition rendering the patient incapable of giving his consent
  • •- Known or suspected allergy to insulin glargine or insulin aspart
  • •- Continuous parenteral nutrition
  • •- Participation in another trial which can influence the software algorithm

研究者

发起方
Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klin. Abt. für Endokrinologie und Stoffwechsel

相似试验

Optimization of glycaemic control using a... | 临床试验